SecBot SecBot
SECBOTREPLAY Home › Report › ORKA

ORKA · Two ORKA insiders, a director and the SVP of Finance, sold $1.01M in…

Oruka Therapeutics, Inc. · CLUSTER filed Jun 15, 2026 at 18:57 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Jun 15, 2026 at 18:57 ET

Two ORKA insiders, a director and the SVP of Finance, sold $1.01M in open-market shares ($882K of that from director Carl Dambkowski alone) in the past week. However, this selling is dwarfed by a much larger, broader cluster spanning 13 trades by 7 insiders in a 7-day window ending June 15 (including the CEO, CMO, COO, and GC), which includes non-cash derivative exercises and follow-on open-market sales. The aggregate open-market selling of ~$2.9M represents only ~0.07% of market cap and is largely consistent with routine post-vesting liquidity sales following recent option exercises, not a bearish informed signal.

  • Two-insider cluster (Director, SVP Finance) sold ~$1.01M open-market over June 5-12.
  • Broader 7-day window includes 13 trades by 7 insiders (CEO, CMO, COO, GC, Director, SVP Finance, other) with $2.9M in open-market sales.
  • Director Carl Dambkowski alone sold 35K shares for ~$2.45M (the dominant seller).
  • CEO Klein sold $120K, CMO Goncalves sold $112K, COO Sandler sold $42K, GC Quinlan sold $51K.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access